Filtered By:
Source: International Journal of Cardiology
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 3.
Order by Relevance | Date
Total 388 results found since Jan 2013.
Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
We read the article “Risk of stroke in congestive heart failure with and without atrial fibrillation” by Kang et al. [1] interestingly, which has great clinical significance in prevention of ischemic stroke during the management of congestive heart failure (CHF) patients. CHF has been shown to be associated with2 t o 3 times higher risk of stroke [2,3], also known as cardioembolism that is due to thrombus formation caused by atrial fibrillation (AF) or stagnation of blood in the left ventricle [4,5].
Source: International Journal of Cardiology - March 3, 2018 Category: Cardiology Authors: Jing Bai, Deliang Shen, Bo Wang, Qing Han, Peiwen Wang, Jinying Zhang Tags: Letter to the Editor Source Type: research
Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice
Atrial fibrillation (AF) can be newly-diagnosed in up to 24% of patients with ischemic stroke [1]. The entity so called “AF detected after stroke” (AFDAS) has been created to acknowledge the complexity of diagnosing and managing these patients [2]. AFDAS may be a pre-existing AF condition that is unknown and/or asymptomatic, and is only diagnosed because of thorough post-stroke electrocardiographic monitoring in a yet unknown proportion of patients. Conversely, it may also be the consequence of neurogenic AF mechanisms triggered by the presence of a stroke.
Source: International Journal of Cardiology - April 13, 2018 Category: Cardiology Authors: Luciano A. Sposato, Renato D. Lopes Tags: Editorial Source Type: research
Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: A systematic review and meta-analysis
Atrial fibrillation has been established as a major risk factor of ischemic stroke, however, the influence of new-onset atrial fibrillation (NOAF) complicating acute coronary syndrome (ACS) on ischemic stroke remains controversial. This meta-analysis aimed to validate the association between NOAF complicating ACS and ischemic stroke.
Source: International Journal of Cardiology - April 23, 2018 Category: Cardiology Authors: Jiachen Luo, Hongqiang Li, Xiaoming Qin, Baoxin Liu, Jinlong Zhao, Guli Maihe, Zhiqiang Li, Yidong Wei Source Type: research
Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice
Atrial fibrillation (AF) can be newly-diagnosed in up to 24% of patients with ischemic stroke [1]. The entity so called “AF detected after stroke” (AFDAS) has been created to acknowledge the complexity of diagnosing and managing these patients [2]. AFDAS may be a pre-existing AF condition that is unknown and/or asymptomatic, and is only diagnosed because of thorough post-stroke electrocardiographic monitoring in a yet unknown proportion of patients. Conversely, it may also be the consequence of neurogenic AF mechanisms triggered by the presence of a stroke.
Source: International Journal of Cardiology - April 26, 2018 Category: Cardiology Authors: Luciano A. Sposato, Renato D. Lopes Tags: Editorial Source Type: research
The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes
Stroke is an important clinical condition associated with increased morbidity and mortality. Despite availability of effective oral anticoagulants (OAC), stroke prevention remains inadequate, particularly in patients with diabetes mellitus [1]. The study by XXXX and colleagues [2] in this issue of the International Journal of Cardiology examined for the first time if diabetes type 1 (T1D) or type 2 (T2D) impact differently on stroke risk specifically in patients with atrial fibrillation (AF). The investigators further explored if timing of OAC initiation once AF is diagnosed differs between T1D and T2D patients.
Source: International Journal of Cardiology - May 19, 2018 Category: Cardiology Authors: Anke C. Fender, Dobromir Dobrev Tags: Editorial Source Type: research
Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation
We investigated whether cardiovascular outcome patterns differ across atrial fibrillation (AF) subgroups defined by age, valvular status, newly diagnosed vs. prevalent cases, or anticoagulation status, and whether stroke risk models can accurately predict non-stroke outcomes.
Source: International Journal of Cardiology - July 27, 2018 Category: Cardiology Authors: Finlay A. McAlister, Natasha Wiebe, Paul E. Ronksley, Jeff S. Healey Source Type: research
Stroke prevention in atrial fibrillation: State of the art
Stroke prevention is the cornerstone of the management of patients with atrial fibrillation (AF). Individual stroke risk stratification is generally the first step of deciding whether oral anticoagulation (OAC) will benefit patients with AF. Given that existing approaches to the prediction of ‘high risk’ subjects are of limited value, the initial focus should be the identification of ‘low-risk’ patients who do not need antithrombotic therapy. For this, the CHA2DS2-VASc score (congestive heart failure, hypertension, age ≥ 75 [2 points], diabetes mellitus, previous stroke/tra nsient ischemic attack [2 points], ...
Source: International Journal of Cardiology - September 19, 2018 Category: Cardiology Authors: Yan-Guang Li, Gregory Y.H. Lip Tags: Review Source Type: research
Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study
Underuse of anticoagulants in ischemic stroke patients with atrial fibrillation (AF) and/or rheumatic heart disease (RHD) is a global concern, especially in China. However, the extent to which anticoagulants are underused in AF and/or RHD-related ischemic stroke in China has not been well characterized. We aimed to explore the temporal trends of AF and/or RHD-related ischemic stroke patients, anticoagulation use and factors related to suboptimal use of anticoagulants in a Chinese population.
Source: International Journal of Cardiology - August 15, 2020 Category: Cardiology Authors: Junfeng Liu, Yanan Wang, Wen Guo, Yajun Cheng, Shihong Zhang, Bo Wu, Ming Liu Source Type: research
Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation
We aimed to assess the prevalence of prior anticoagulation therapy (warfarin or non-vitamin K antagonist oral anticoagulants [NOACs]) among patients with acute ischemic stroke (AIS) and atrial fibrillation (AF) in China and investigate the associations between prior anticoagulation therapy and initial stroke severity and in-hospital outcomes.
Source: International Journal of Cardiology - May 29, 2023 Category: Cardiology Authors: Lue Zhou, Yapeng Li, Xin Yang, Hongqiu Gu, Yanran Duan, Hang Fu, Anran Wang, Kai Liu, Yuan Gao, Bo Song, Yusheng Li, Yingyu Jiang, Jing Zhang, Chunjuan Wang, Meng Wang, Zixiao Li, Yuming Xu, Chengzeng Wang, Yongjun Wang Source Type: research
ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NA ÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
We assessed the cumulative incidence of recurrent stroke, major bleeding and all-cause mortality associated with restarting antithrombotic treatment, in patients experiencing an anticoagulation-related event (stroke or major bleeding), occurred during anticoagulation therapy for AF.Methods and Results.We performed a retrospective population-based analysis on linked claims data of patients resident in the Veneto Region, treated with DOACs for AF and discharged (2013 −2020) from the hospital for stroke, intracranial haemorrhage (ICH), and major bleeding.
Source: International Journal of Cardiology - September 16, 2023 Category: Cardiology Authors: N. Gennaro, E. Ferroni, M. Zorzi, G. Denas, V. Pengo Source Type: research
Assessment of stroke risk in Middle Eastern patients with atrial fibrillation: The Gulf SAFE registry
Limited data are available on the epidemiology of AF in non-European, non-Caucasian populations . The aim of the present study was to present the thromboembolic risk profile and for the first time, to validate the performance of the CHADS2 (congestive heart failure, hypertension, age ≥75years, diabetes, stroke/TIA doubled) and CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75years doubled, diabetes, stroke/TIA doubled, vascular disease, age 65–74, sex category [female]) scores in a Middle Eastern population.
Source: International Journal of Cardiology - March 7, 2013 Category: Cardiology Authors: S. Apostolakis, M. Zubaid, W.A. Rashed, A.A. Alsheikh-Ali, W. Almahmeed, A. Shehab, K. Sulaiman, A. AlQudaimi, N. Asaad, H. Amin, D.A. Lane, G.Y.H. Lip, On behalf of the Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Investigators Tags: Letters to the Editor Source Type: research
Digoxin use is associated with increased risk of stroke in patients with non-valvular atrial fibrillation — a nationwide population-based cohort study
Atrial fibrillation (AF) is associated with increased risk of morbidity and mortality. Digoxin is often used as a rate control agent in AF patients, particularly in those with systolic heart failure. Although digoxin use in AF patients can reduce heart failure symptoms, increase exercise capacity and decrease hospitalizations , unfavorable effects on long-term outcomes have been reported . In the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study, a post-hoc analysis showed a higher rate of mortality in patients treated with digitalis medication . A study of the “Registry of Information and K...
Source: International Journal of Cardiology - September 23, 2013 Category: Cardiology Authors: Shih-Sheng Chang, Kuan-Cheng Chang, Yu-Chen Wang, Chih-Hsin Muo, Pei-Ying Pai, Chi-Bin Chang, Chi-Yuan Li, Fung-Chang Sung Tags: Online Letters to the Editor Source Type: research
Stroke and urosepsis after discontinuation of rivaroxaban
We report a patient with stroke shortly after discontinuation of rivaroxaban with a complicated course.
Source: International Journal of Cardiology - November 4, 2013 Category: Cardiology Authors: Claudia Stöllberger, Josef Finsterer Tags: Online Letters to the Editor Source Type: research
Simultaneous onset of myocardial infarction and ischemic stroke in a patient with atrial fibrillation: Multiple territory injury revealed on angiography and magnetic resonance
An 84-year-old man with a history of hypertension and paroxysmal atrial fibrillation (AF) who received no anticoagulant drugs experienced acute chest pain and transient loss of consciousness. He was transferred to our emergency room. His initial electrocardiogram showed sinus rhythm with ST-segment elevation in the I, aVL, and V1–V6 leads. His blood pressure was 158/92mmHg and his pulse was regular at 70beats per minute. A chest radiograph showed increased heart size and pulmonary vascular congestion. His troponin T level was elevated (more than 0.1ng/mL). He was diagnosed with ST-elevation myocardial infarction (MI) and...
Source: International Journal of Cardiology - February 4, 2014 Category: Cardiology Authors: Osamu Hashimoto, Kozo Sato, Yohei Numasawa, Joji Hosokawa, Masahiro Endo Tags: Online Letters to the Editor Source Type: research
